SUTTI, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 1.934
NA - Nord America 1.928
AS - Asia 1.241
SA - Sud America 149
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 60
OC - Oceania 2
Totale 5.403
Nazione #
US - Stati Uniti d'America 1.871
RU - Federazione Russa 467
SG - Singapore 382
IE - Irlanda 314
IT - Italia 298
DE - Germania 281
CN - Cina 226
HK - Hong Kong 191
VN - Vietnam 160
SE - Svezia 155
BR - Brasile 113
FR - Francia 105
UA - Ucraina 95
IN - India 75
FI - Finlandia 61
GB - Regno Unito 54
KR - Corea 46
BD - Bangladesh 42
ID - Indonesia 34
CA - Canada 27
PL - Polonia 27
BJ - Benin 25
BE - Belgio 21
AR - Argentina 20
NL - Olanda 19
TR - Turchia 19
MX - Messico 18
JP - Giappone 17
ZA - Sudafrica 12
AT - Austria 10
ES - Italia 8
IQ - Iraq 8
CZ - Repubblica Ceca 7
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
DZ - Algeria 4
EC - Ecuador 4
IR - Iran 4
LT - Lituania 4
MA - Marocco 4
NG - Nigeria 4
NP - Nepal 4
PY - Paraguay 4
JM - Giamaica 3
PH - Filippine 3
SA - Arabia Saudita 3
VE - Venezuela 3
AU - Australia 2
CH - Svizzera 2
CO - Colombia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
KE - Kenya 2
LB - Libano 2
SN - Senegal 2
TN - Tunisia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.316
Città #
Dublin 305
San Jose 245
Hong Kong 190
Council Bluffs 167
Jacksonville 160
Singapore 147
Ashburn 133
Dearborn 82
Beijing 67
Munich 65
Chandler 59
Columbus 57
Los Angeles 53
Moscow 50
Ho Chi Minh City 48
Seoul 45
Milan 43
Lauterbourg 42
Novara 42
Wilmington 42
New York 38
Santa Clara 35
Hanoi 34
Turin 34
Lawrence 33
Princeton 33
Jakarta 28
Buffalo 27
Dallas 27
Piemonte 27
Cotonou 25
Ann Arbor 22
Bremen 21
Brussels 20
Grafing 20
St Louis 20
Strasbourg 20
Warsaw 20
Frankfurt am Main 19
Dong Ket 18
Helsinki 18
London 18
Brooklyn 17
Phoenix 14
Monmouth Junction 13
Nuremberg 13
San Mateo 13
Andover 12
Falkenstein 12
Houston 12
Orem 12
The Dalles 12
Tokyo 12
Amsterdam 11
Denver 11
Guangzhou 11
Stockholm 11
Atlanta 10
Chennai 10
Kocaeli 10
Mumbai 10
Poplar 10
Rome 10
São Paulo 10
Boston 9
Hangzhou 9
Johannesburg 9
Nanjing 9
Tianjin 9
Toronto 9
Vercelli 9
Haiphong 8
Mexico City 8
Montreal 8
Odalengo Grande 8
Chicago 7
Kunming 7
Mülheim 7
Redondo Beach 7
Turku 7
Woodbridge 7
Assago 6
Gdynia 6
Genoa 6
Leawood 6
Manchester 6
Vienna 6
Ankara 5
Augusta 5
Baghdad 5
Berlin 5
Brno 5
Charlotte 5
Da Nang 5
Bulandshahr 4
Can Tho 4
Cassano Magnago 4
Fairfield 4
Norwalk 4
Querétaro 4
Totale 3.087
Nome #
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair 176
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis 156
CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation 149
Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice 147
CX3CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury 147
Vegetal oil-based ketogenic diet improves inflammation and fibrosis in experimental metabolic dysfunction-associated steatohepatitis 146
CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis 146
Role of Balanced Involvement of the ICOS/ICOSL/Osteopontin Network in Cutaneous Wound Healing 144
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH) 142
From MASLD to HCC: What's in the middle? 141
Adaptive immunity: an emerging player in the progression of NAFLD 141
Adenosine A2a receptor stimulation prevents hepatocyte lipotoxicity and nonalcoholic steatohepatitis (NASH) in rats. 135
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH 133
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review 126
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease 123
CYP2E1 autoantibodies in liver diseases 117
The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: A 2015 update 117
Is there a role for adaptive immunity in nonalcoholic steatohepatitis? 114
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. 114
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 112
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 111
Notch signaling and progenitor/ductular reaction in steatohepatitis. 111
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein 111
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications 107
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation 105
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation 102
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 100
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. 100
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 99
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts 98
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis 97
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo 96
Conformational anti-cytochrome P4502E1 auto-antibodies contributes to necro-inflammatory injury in chronic hepatitis C 93
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets 92
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 91
Liver inflammation and regeneration in drug-induced liver injury: Sex matters! 91
Interplay between oxidative stress and steatosis in the progression of Hepatitis C 90
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 90
Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry 89
Oxidative stress parameters in paediatric non-alcoholic fatty liver disease 84
NF-kB1 deficiency stimulates the progression of nonalcoholic steatohepatitis (NASH) in mice by promoting NKT-mediated responses 84
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 84
The paradox role of cytotoxic T-lymphocytes in NAFLD-associated hepatocellular carcinoma 76
Immune response against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α in heavy drinkers 75
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 75
Editorial: Inflammatory responses on the road from NASH to HCC: pathogenic mechanisms and possible therapeutic strategies 73
Inflammatory processes involved in NASH-related hepatocellular carcinoma 68
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses 63
ICOSL: more than a trigger of ICOS function 55
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion 30
Dietary Fructose Alters Duodenal Mucin Glycosylation and Mucus Production in High-Fat Diet-Fed Mice 25
When the Liver Flares: Inflammatory and Immunometabolic Mechanisms Driving the Transition from MASLD to MASH 9
Diets Differently Affect Bone Health: Murine Models 3
Totale 5.403
Categoria #
all - tutte 25.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022302 0 19 17 10 17 31 35 7 19 24 49 74
2022/2023690 75 31 39 14 49 66 31 21 316 2 33 13
2023/2024242 18 21 13 3 35 7 50 5 9 5 43 33
2024/2025729 8 8 45 12 31 64 102 76 117 59 26 181
2025/20262.482 106 116 149 296 260 155 371 369 173 251 139 97
2026/2027242 93 149 0 0 0 0 0 0 0 0 0 0
Totale 5.403